Mark Price
Impact in
-
- Neutropenia and Cancer Infections
- Viral-associated cancers and disorders
Papers in
- Epidemiology 11
- Inflammatory Myopathies and Dermatomyositis 4
- Oncology 9
- Cutaneous Melanoma Detection and Management 2
- Lung Cancer Research Studies 2
- Neutropenia and Cancer Infections 2
- Co-authors
- G.A. Kerkut (2 shared papers)Robert M. Pearl (1 shared paper)Glenn D. Goldstein (1 shared paper)Sheri Fehnel (3 shared papers)Dana DiBenedetti (2 shared papers)Malcolm J. York (1 shared paper)Emmanuel Saez (1 shared paper)Mark W. Frank (1 shared paper)
- Journals
- Toxicologic Pathology (3 papers)Journal of Clinical Oncology (3 papers)Value in Health (3 papers)Lung Cancer (2 papers)Supportive Care in Cancer (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Mark Price
58 papers receiving 719 citations
Peers
Comparison fields: 5 of 132
- Oncology 99
- Rheumatology 43
- Dermatology 24
- Epidemiology 90
- Pharmacology 23
Countries citing papers authored by Mark Price
This map shows the geographic impact of Mark Price's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Price with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Price more than expected).
Fields of papers citing papers by Mark Price
This network shows the impact of papers produced by Mark Price. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Price. The network helps show where Mark Price may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Price, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 61 | |
| 2 | 2001 | 48 | |
| 3 | 2016 | 43 | |
| 4 | 2002 | 43 | |
| 5 | 2018 | 40 | |
| 6 | Frank-Sommeiller-Price Series for Top Income Shares by US States since 1917 | 2015 | 34 |
| 7 | 2015 | 32 | |
| 8 | 1993 | 31 | |
| 9 | 2012 | 30 | |
| 10 | 2018 | 28 | |
| 11 | 1994 | 23 | |
| 12 | 2022 | 22 | |
| 13 | 2014 | 22 | |
| 14 | 1997 | 19 | |
| 15 | 2008 | 18 | |
| 16 | 2016 | 17 | |
| 17 | 2020 | 16 | |
| 18 | 1964 | 16 | |
| 19 | 2011 | 15 | |
| 20 | 2001 | 13 |
About Mark Price
Mark Price is a scholar working on Epidemiology, Oncology, Rheumatology, Surgery and Molecular Biology, having authored 59 papers that have together received 737 indexed citations. Recurring topics across this work include Inflammatory Myopathies and Dermatomyositis (4 papers), Spondyloarthritis Studies and Treatments (3 papers), Cutaneous Melanoma Detection and Management (2 papers), Lung Cancer Research Studies (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Epilepsy research and treatment (2 papers), Asthma and respiratory diseases (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Oncology (99 citations), Rheumatology (43 citations), Dermatology (24 citations), Epidemiology (90 citations) and Pharmacology (23 citations). Mark Price has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include G.A. Kerkut, Robert M. Pearl, Glenn D. Goldstein, Sheri Fehnel, Dana DiBenedetti, Malcolm J. York, Emmanuel Saez, Mark W. Frank, James A. Kaye and Costel Chirila. Their work appears in journals such as Toxicologic Pathology, Journal of Clinical Oncology, Value in Health, Lung Cancer and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.